Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1258 of 5804
-
New eczema cream shows promise in early trial
Symptom relief CompletedA multicenter, randomized, double-blind, vehicle controlled phase II clinical study
Phase: PHASE2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Balloons may beat stents for tough heart blockages
Disease control Recruiting nowThe aim of this study is to evaluate the long-term efficacy and safety of drug-coated balloon (DCB) strategies, including DCB alone or hybrid strategies of DCB and drug-eluting stent (DES), compared to DES-only in patients with chronic total occlusion (CTO) after successful recan…
Phase: NA • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug BL-M14D1 targets tough cancers in early human trial
Disease control Recruiting nowThe objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Neoplasms
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Weekly shot could replace daily needles for short kids
Disease control Recruiting nowThis is a multicenter, randomized, open-label, active-controlled Phase III clinical trial to evaluate the efficacy and safety of Inpegsomatropin injection,once a week,compared with recombinant human growth hormone (rhGH) in children with idiopathic short stature (ISS). It plans t…
Phase: PHASE3 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Ketamine tested as new hope for long COVID brain fog and exhaustion
Symptom relief CompletedPlain Language Summary: This study is a clinical trial to see if ketamine can help treat symptoms of Long COVID, especially fatigue and problems with thinking clearly (often called "brain fog"). Long COVID is a condition that affects people even after they have recovered from CO…
Phase: PHASE2 • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Can a website ease the emotional toll of stem cell transplants?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if using an intervention website (Mosaic) improves selected patient-reported outcomes in adult blood cancer patients undergoing allogeneic or autologous stem cell transplant, compared to using an educational website (control group). Pat…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Common painkiller ibuprofen tested as treatment for heart inflammation
Disease control Recruiting nowProspective, randomized, multicenter, open-label clinical trial to evaluate the safety and efficacy of a 3-week ibuprofen tapering regimen compared to conventional analgesic treatment (acetaminophen) in patients with acute myocarditis and left ventricular ejection fraction ≥50%. …
Phase: PHASE3 • Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New radioactive antibody could make sickle cell transplants safer
Disease control Recruiting nowThe purpose of this study is to find the smallest amount of the 131 I-apamistamab needed for preparing patients with severe sickle cell disease (SCD) for a bone marrow transplant. This is the first time 131 I-apamistamab is being used for advanced Sickle Cell Disease (SCD) in the…
Phase: PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a gentle forehead zap during sleep ease ADHD in kids with fetal alcohol exposure?
Symptom relief Recruiting nowThis is an open-label trial of trigeminal nerve stimulation (TNS) for children aged 8-12 years with attention deficit hyperactivity disorder (ADHD) putatively due to prenatal alcohol exposure (PAE). TNS has been successful in treating pediatric ADHD generally and it is US Food an…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Could sound waves wake the brain? new trial tests ultrasound for severe injury
Disease control Recruiting nowThe overall aim of this study is to develop an intervention that can help recovery in patients surviving severe brain injury but failing to fully recover. In particular, this multicenter project aims to (1) establish short-term efficacy of tFUS as a therapeutic to promote recover…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Custom skull cap may stop brain sinking after Life-Saving surgery
Disease control Recruiting nowPatients that undergo decompressive craniectomy are at risk of delayed changes in brain function known as "Sunken Flap Syndrome" or "Syndrome of the Trephined." The goal of this clinical trial is to see if placing a prosthetic over patients' skull defects can prevent "Sunken Flap…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could a hormone shield bile ducts in transplanted livers?
Disease control ENROLLING_BY_INVITATIONThe main objective is to assess whether the use of human synthetic secretin in a clinical (COR-)NMP procedure can restore physiological HCO3- content of the bile during ex-situ NMP.
Phase: PHASE1, PHASE2 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Cord stem cells tested for Life-Threatening lung failure
Disease control Recruiting nowPrimary Objective: To evaluate the safety and tolerability of human umbilical cord mesenchymal stem cell injection in the treatment of moderate/severe acute respiratory distress syndrome.Secondary Objectives: To explore the efficacy and appropriate dosage of human umbilical cord …
Phase: PHASE1, PHASE2 • Sponsor: Changchun Tuohua Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for nonverbal kids with autism: simple play-based therapy boosts speech
Symptom relief Recruiting nowThirty percent of children with autism barely talk or do not talk at all despite years of intervention. This study aims to address this important and long-standing challenge by developing a novel intervention to increase the quantity and quality of vocalizations (i.e., sounds chi…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Lab-Grown eye cells injected to reverse corneal blindness
Disease control OngoingCulture endothelial cells harvested from donor corneal tissue to treat corneal endothelial cell dysfunction. After ex vivo cultivation, the cells will be injected into anterior chamber and endothelial cells will settle down and adhere to the denuded Descemet's membrane. Eventuall…
Phase: PHASE1 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Brain zap plus mind control: new combo aims to restore arm movement after stroke
Symptom relief Recruiting nowCerebrovascular accidents (strokes) are a major public health issue. Stroke is the 3rd leading cause of death and the leading cause of disability and loss of autonomy. In France, there are currently 130,000 new cases per year, and the aging of the population will lead to an incre…
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
One-Day fix for big liver tumors? new study tests Same-Day radiation
Disease control Recruiting nowIn patients who has no sign suggesting high lung shunt fraction (TIPS, hepatic vein invasion, hepatic vein enhancement on arterial phase, dysmorphic intratumoral vessel), planning angiography, MAA scan, and radioembolization are performed in a single day with SIR-Spheres. This pr…
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for Hard-to-Treat cancers: first human trial of ISM3412 begins
Disease control Recruiting nowThe study has consists of two parts, a dose escalation part (Part 1) and a dose selection optimization part (Part 2). The primary objectives of this study are to evaluate the safety and tolerability of ISM3412 in participants with locally advanced/metastatic solid tumors, and to …
Phase: PHASE1, PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug mimics natural protein to calm overactive immune system in nerve disease
Disease control OngoingThe purpose of the study is to evaluate the safety of NVG-2089 and to evaluate how well patients respond to this investigational treatment. NVG-2089 is a new drug that is being developed for treating patients with CIDP. NVG-2089 is designed to mimic the effects of a protein calle…
Phase: PHASE2 • Sponsor: Nuvig Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Quick blood transfusions may keep seniors Clear-Headed after hip surgery
Disease control Recruiting nowThe goal of this clinical trial is to investigate whether early detection of bleeding and prompt blood transfusions can help prevent delirium in patients aged 75 and older who are admitted to the hospital with hip fractures. The main question the trial aims to answer is: Do pati…
Phase: NA • Sponsor: University of Aarhus • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC